Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients

Estrogen receptor-positive (ER+) breast cancer generally confers a more favorable prognosis than ER-negative cancer, however, a different picture is emerging for BRCA2 mutation carriers and young patients. We used nationwide data from population-based registries to study prognostic effects in those...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidarsdottir, Linda, Olafsdottir, Elinborg J., Barkardottir, Rosa B., Bjarnadottir, Olöf, Jonasson, Jon G., Sigurdsson, Stefan, Tryggvadottir, Laufey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689749/
https://www.ncbi.nlm.nih.gov/pubmed/38036573
http://dx.doi.org/10.1038/s41523-023-00600-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689749/
https://www.ncbi.nlm.nih.gov/pubmed/38036573
http://dx.doi.org/10.1038/s41523-023-00600-8

Ejemplares similares